(PharmaNewsWire.Com, September 15, 2017 ) North America is expected to account the highest share in the market followed by Asia-Pacific and Europe owing to rising incidence of infectious diseases, and increasing aging population.
Infectious diseases market are caused by microorganisms, such as bacteria, viruses, parasites and fungi. These diseases can be spread, directly or indirectly, from one individual to another. Anti-infective drugs are used to prevent the growth of such infection/diseases. These drugs can act directly on host defence system which targets the causative agent. Infectious diseases such as malaria, HIV, tuberculosis, influenza, hepatitis A and salmonella pose a major challenge for public.
North America Market is primarily driven factors such as increasing occurrence of infectious diseases, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. The major factors challenging the growth of the market is generic erosion, Patent expiration of infectious disease drugs.
Based on Treatment, the market is segmented into Drugs and Vaccines. The drugs are further segmented into oral administration, topical, injections and others. Based on target organism the market is segment into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type the market is segmented into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, clinics and others. Based on Geography, the North America Infectious disease therapeutics market is analyzed under various regions namely U.S, Canada.
Major companies dominating the North America Infectious disease Therapeutics Market F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
